Trading Signals: ADMS Stock Price Prediction and Forecast (Thu. Apr. 10, 2014 - Mon. Aug. 9, 2021)(Adamas Pharmaceuticals Inc)
| ADMS latest price $5.2900 (4.86%) ($5.2900 - $5.2900) on Tue. Mar. 2, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.78% (three month average) | RSI | 30 | Latest Price | $5.2900(4.86%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ADMS advances 0.6% a day on average for past five trading days. | Weekly Trend | ADMS declines -10.5% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ADMS advance at 0% a week (0% probability) FXI(17%) MCHI(11%) TLT(9%) VWO(7%) XLC(7%) | Factors Impacting ADMS price | ADMS will decline at least -2.39% in a week (0% probabilities). JETS(-27%) VCSH(-18%) REMX(-17%) CEMB(-17%) XLY(-14%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.39% (StdDev 4.78%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-11.27(-313.04%) | Inflection Point | Yes | Resistance Level | $5.62 | 5 Day Moving Average | $4.9(7.96%) | 10 Day Moving Average | $5.27(0.38%) | 20 Day Moving Average | $5.62(-5.87%) | To recent high | -20.6% | To recent low | 5.8% | Market Cap | $150m | | | | Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. |